HEALTH

Sweden’s drugmaker Camurus eyes US expansion with potential Braeburn buyout

Swedish biotech Camurus, known for developing long-acting treatments for chronic conditions, is reportedly in talks to buy US-based Braeburn Pharmaceuticals Inc. The deal, if...

See how Sweden contributed to the new EU pharmaceutical legislation

After two years of negotiations, EU Member States have reached an agreement on revised pharmaceutical legislation. This process faced significant challenges, particularly regarding data...

European Vaccine Hub to enhance EU’s responsiveness to pandemics

The COVID-19 pandemic and previous health emergencies have emphasised the critical need to enhance technologies that facilitate rapid responses in times of crisis. A...

Commission strengthens its preparedness for potential influenza pandemic

The European Union is actively enhancing its preparedness for a potential flu pandemic. The European Commission has signed a new joint procurement contract through...

An EU Action Plan on rare diseases

A high-level conference convened in Warsaw on April 10, 2025, under the Polish Presidency of the Council of the European Union, focused on the...

Popular